Universal Health Services Releases 2024 Annual Report Universal Health Services (NYSE: UHS), one of the nation’s largest and most respected providers of hospital and healthcare services, has unveiled its 2024…
Morris & Dickson Expands 3PL Services with Presa Solutions Acquisition Morris & Dickson Inc., a prominent pharmaceutical wholesaler and specialty distributor, has announced its acquisition of Presa Solutions, a leading…
Geneoscopy Appoints Amit Bhalla as CFO to Drive Growth and Commercialization Geneoscopy, Inc., a life sciences company focused on advancing gastrointestinal health through innovative diagnostic tests, has announced the appointment…
GE HealthCare and FPT Expand AI-Powered Healthcare Partnership Global IT leader FPT Corporation and GE HealthCare have announced an expanded Strategic Cooperation Agreement aimed at driving innovation in AI-powered healthcare…
Enigma Biomedical Partners to Use 4R PET Imaging Biomarkers in CTE Research Enigma Biomedical USA, Inc. (EB USA) has announced an exciting new collaboration with the Boston University Chronic Traumatic…
SBC Medical Group Reports Q4 and Full Year 2024 Financial Results SBC Medical Group Holdings Incorporated (NASDAQ: SBC), a global leader in aesthetic practice management services and products, has announced…
Colorectal Cancer Screening and Diagnostics Market Report Summary Market Overview The “Colorectal Cancer Screening and Diagnostics Market” report provides an in-depth analysis of the colorectal cancer screening and diagnostic testing…
Health Canada Approves 4Moving Biotech’s Phase 2a Trial for Knee Osteoarthritis 4Moving Biotech (4MB), a pioneering biotechnology company and a spin-off of 4P-Pharma, has received authorization from Health Canada to…
FDA Approves Blujepa (Gepotidacin) for Uncomplicated UTIs in Patients 12+ GSK plc (LSE/NYSE: GSK) has announced that the US Food and Drug Administration (FDA) has approved Blujepa (gepotidacin) for the…
Revvity & Genomics England Expand Partnership for Newborn Genomic Research Revvity, Inc. (NYSE: RVTY) has expanded its collaboration with Genomics England to further support the groundbreaking Generation Study, a national…
ClostraBio Secures INVENT Illinois Investment, Names New CSO, Plans 2025 Product Launch ClostraBio, Inc., a pioneering biotechnology company dedicated to harnessing natural pathways for gut health management, has announced new…
Signum Surgical Appoints Carol Burns as CEO to Lead Commercialization of BioHealx® Signum Surgical (‘Signum’ or ‘the Company’), a medical technology company developing innovative solutions for colorectal diseases, has announced…